These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6459049)

  • 21. [Initial treatment of the menopausal syndrome. Results of a field study (author's transl)].
    Begic S
    Schweiz Rundsch Med Prax; 1978 Sep; 67(36):1317-22. PubMed ID: 683961
    [No Abstract]   [Full Text] [Related]  

  • 22. [Therapeutic trial of medroxyprogesterone acetate in severe fibrocystic breast disease].
    Peralta O; Campodónico I
    Rev Chil Obstet Ginecol; 1983; 48(3):146-55. PubMed ID: 6241963
    [No Abstract]   [Full Text] [Related]  

  • 23. [Surprising effect of the treatment with progesterone of desmoid tumors (aggressive fibromatosis)].
    Lanari A
    Medicina (B Aires); 1985; 45(2):105-9. PubMed ID: 2945067
    [No Abstract]   [Full Text] [Related]  

  • 24. [The effect of hexestrol on the breast in climacteric women (author's transl)].
    Kubista E; Grünberger W; Wolf G
    Wien Med Wochenschr; 1979 Jan; 129(1):16-9. PubMed ID: 419761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Requiem for hormone replacement therapy? This does not apply to modern preparations!].
    Lippert TH; Mueck AO
    MMW Fortschr Med; 2003 Sep; 145(37):13; author reply 13-4. PubMed ID: 14584434
    [No Abstract]   [Full Text] [Related]  

  • 26. [Microbiological hydroxylation of 6 alpha-methyl-17 alpha-hydroxy progesterone and 6 apha-methyl-17 alpha-hydroxy-11-deoxycorticosterone-21-acetate (author's transl)].
    Cai ZY; Gao ZQ; Peng B; Yu XD
    Yao Xue Xue Bao; 1981 May; 16(5):342-8. PubMed ID: 7246179
    [No Abstract]   [Full Text] [Related]  

  • 27. [Medroxyprogesterone acetate in the treatment of recurrent vaginal candidiasis].
    Presl J
    Cesk Gynekol; 1988 Aug; 53(7):528-9. PubMed ID: 2971462
    [No Abstract]   [Full Text] [Related]  

  • 28. [Contribution to the treatment of climacteric syndrome (author's transl)].
    Pontuch A; Blasková O; Becková A; Sasko A
    Bratisl Lek Listy; 1981 Mar; 75(3):345-8. PubMed ID: 7030459
    [No Abstract]   [Full Text] [Related]  

  • 29. [Psychometric aspects of estrogen therapy in the climacteric. Quantification of the psychotropic effect of hormones in 122 women (author's transl)].
    Wenderlein JM
    MMW Munch Med Wochenschr; 1980 Mar; 122(12):419-22. PubMed ID: 6769003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparative study of several types of treatment of the menopausal syndrome (author's transl)].
    Kölblová V; Laitl J; Horský J
    Cesk Gynekol; 1973 Sep; 38(8):629-30. PubMed ID: 4765145
    [No Abstract]   [Full Text] [Related]  

  • 31. [Are the estrogens in the climacteric necessary, superfluous or harmful? (author's transl)].
    Hauser GA
    Ther Umsch; 1974 Mar; 31(3):197-8. PubMed ID: 4816759
    [No Abstract]   [Full Text] [Related]  

  • 32. [Medical treatment of prostatic adenoma].
    Schulman CC; Chantrie M; Giannakopoulos X; De Sloover CR
    Brux Med; 1979 Oct; 59(10):467-70. PubMed ID: 94841
    [No Abstract]   [Full Text] [Related]  

  • 33. Hormone therapy in advanced breast cancer: high dose medroxyprogesterone acetate (MAP) vs tamoxifen (TMX). Preliminary results.
    Pannuti F; Martoni A; Fruet F; Strocchi E; Di Marco AR
    Eur J Cancer (1965); 1980; Suppl 1():93-8. PubMed ID: 6459237
    [No Abstract]   [Full Text] [Related]  

  • 34. Anabolizing and anti-pain effect of the short-term treatment with medroxyprogesterone acetate (MAP) at high oral doses in oncology.
    Pannuti F; Burroni P; Fruet F; Piana E; Strocchi E; Di Marco AR; Cricca A; Camaggi CM
    Panminerva Med; 1980; 22(3):149-56. PubMed ID: 6451859
    [No Abstract]   [Full Text] [Related]  

  • 35. "Mad pursuits"--markers of cell activity?
    Byrjalsen I; Thormann L
    Fertil Steril; 1991 Jun; 55(6):1210-1. PubMed ID: 1828045
    [No Abstract]   [Full Text] [Related]  

  • 36. [Results of a pilot study with high-dose medroxyprogesterone acetate in the treatment of metastasizing breast carcinoma].
    Castiglione M; Cavalli F
    Schweiz Med Wochenschr; 1980 Jul; 110(27-28):1073-6. PubMed ID: 7423153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pregnancy with X-autosome translocation.
    Katayama KP; Valencia AL; Wise L; Stehlik E
    Fertil Steril; 1991 Feb; 55(2):438-9. PubMed ID: 1846826
    [No Abstract]   [Full Text] [Related]  

  • 38. Plasma leptin in postmenopausal women with coronary artery disease: effect of transdermal 17beta-estradiol and intermittent medroxyprogesterone acetate.
    Os I; Os A; Abdelnoor M; Larsen A; Birkeland K; Westheim A
    Climacteric; 2003 Sep; 6(3):204-10. PubMed ID: 14567768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Immunodepressive action and effects of medroxyprogesterone acetate on the lymphatic tissue of the rabbit appendix].
    Laurentaci G; Catalano A; Altomare D
    Arch Sci Med (Torino); 1982; 139(2):203-10. PubMed ID: 6215911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medroxyprogesterone acetate treatment reduces serum interleukin-6 levels in patients with metastatic breast carcinoma.
    Yamashita J; Hideshima T; Shirakusa T; Ogawa M
    Cancer; 1996 Dec; 78(11):2346-52. PubMed ID: 8941005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.